Patients with heart failure (HF) and their families experience stress and suffering from a variety of sources over the course of the HF experience. Palliative care is an interdisciplinary service and an overall approach to care that improves quality of life and alleviates suffering for those living with serious illness, regardless of prognosis. In this review, we synthesize the evidence from randomized clinical trials of palliative care interventions in HF. While the evidence base for palliative care in HF is promising, it is still in its infancy and requires additional high-quality, methodologically sound studies to clearly elucidate the role of palliative care for patients and families living with the burdens of HF. Yet, an increase in attention to primary palliative care (e.g., basic physical and emotional symptom management, advance care planning), provided by primary care and cardiology clinicians, may be a vehicle to address unmet palliative needs earlier and throughout the illness course.
INTRODUCTION
Heart failure (HF) is a chronic, progressive, and ultimately lethal disease that affects more than 6 million American adults, with an additional 870,000 individuals diagnosed annually (1) . Despite advances in HF therapies, nearly 40% of patients will die within a year of their first hospitalization (2) . During the course of HF, patients typically experience debilitating physical and emotional symptoms, loss of independence, and disruptions to social roles, all of which severely degrade quality of life (QoL) (3, 4) . Physical symptoms in advanced HF, such as pain, are highly distressing for patients and caregivers, yet remain under-recognized and undertreated (5, 6) . Patients and their caregivers (7, 8) often face decisions about high-risk and complex treatments (e.g., cardiac devices, transplantation) without adequate prognosis communication, decision support, or advance care planning (9, 10) . In addition, HF management poses enormous financial and resource stress on families, healthcare systems, and society; direct medical costs of HF are projected to be more than $77 billion by 2030, a 215% increase from current spending (11) .
Palliative care is an interdisciplinary approach, as well as a clinical subspecialty that focuses on improving QoL and reducing suffering among patients with serious illness and their families (12) . Core domains of palliative care interventions include: expert assessment of pain and other physical symptoms, psychosocial care, identification of goals of care, and support for complex treatment and decision making. A recent systematic review and meta-analysis of palliative care interventions suggests that a palliative approach is associated with improved patient QoL, reduced symptom burden, and improved caregiver outcomes (13) . However, most evidence for palliative care emanates from oncology; the role of palliative care in chronic, nonmalignant illnesses such as HF is underdeveloped (13) .
Palliative care takes many forms. Historically, a sub-specialty trained palliative care specialist works alongside patients' primary clinicians to consult on or co-manage patients' palliative needs. Alternatively, primary palliative care (or "basic" or "generalist" palliative care)
is the concept that all clinicians, regardless of specialization, should be competent in fundamental palliative skills (14) . These skills include basic physical and emotional symptom management, initial goals of care discussions, and patient referral to specialty palliative care or, for patients at the end of life, hospice care. Palliative care also varies by the location of service.
More than 65% of U.S. hospitals have a specialty palliative care program which delivers services to inpatients (15) . Community-and outpatient-based palliative care models have been regarded as the "new frontier" in supporting patients and families longitudinally and across a variety of care settings (16) .
In this review, we describe the potential role of palliative care in improving outcomes in patients with HF, characterize typical palliative care delivery models and each model's existing evidence, and describe future priorities for palliative care research and clinical practice models in HF.
NATURAL OPPORTUNITIES TO INTEGRATE PALLIATIVE DOMAINS IN HF CARE
Historically, the prevailing approach to palliative care has been one of a zero-sum game; palliative and curative therapies have been erroneously regarded as contradictory options (17) . It is no longer appropriate to assume that palliative care should be initiated only as a treatment of last resort when traditional HF management fails to fulfill a patient's goals. Particularly given the unpredictable trajectory of HF, waiting for a "trigger" event at which to initiate a palliative approach -either primary palliative care or specialty palliative care consultation -perpetuates the false dichotomy of palliative versus (rather than palliative plus) life-prolonging therapy. In fact, there are often multiple natural opportunities to consider integrating various palliative domains throughout the HF trajectory (Central Illustration). For many patients, primary palliative care, such as basic symptom management and identifying a surrogate decision maker is provided by a primary care, cardiology, or HF clinician. Palliative care specialists can assist with the management of intractable symptoms, and more complex medical decision-making, such as instances of discordant patient-family goals or irresolvable unrealistic expectations of medical therapies. Recognizing the potential discordance between objective measures of disease severity (e.g., ejection fraction) and patient-reported outcomes (e.g., symptom burden, QoL), it is important that patient-reported outcomes, such as symptoms and QoL be monitored regularly throughout the entire HF experience by primary care and/or cardiology providers, so as to facilitate optimal patient-centered care. Ultimately, the optimal timing for integrating primary or specialty palliative care for patients with advanced HF will vary, reflecting patient need, not prognosis.
Poorly controlled symptoms and psychosocial-spiritual distress
Patients with HF often have a wide array of symptoms, including dyspnea, pain, anxiety, depression, sleep disturbance, and fatigue (18, 19) . There are varying levels of evidence for treating HF symptoms (20) . Often, the ideal HF symptom management approach is treating the underlying HF condition (e.g., relieving dyspnea by addressing fluid overload); this is a clear example of the harmony between traditional HF disease management and a palliative approach (21) . However, many symptoms persist despite optimal disease management. For example, pain is common, yet under-recognized and therefore undertreated in HF (5) . Similarly, depression occurs in an estimated 1 in 5 patients with HF, and is associated with worse QoL and increased mortality (22) ; yet routine screening for depression in HF is rare (23, 24) .
The psychosocial-spiritual context of HF beyond depression and anxiety is understudied (25) . The HF experience is rife with uncertainty, existential distress, and adjustment to modified social and professional roles. Additionally, patients considering advanced therapies such as VADs and cardiac transplantation face additional anxieties as they anticipate or adjusting to a new life post-receipt. In addition to limitations in personal roles, patients experience wide variability in social support and the availability of informal caregivers (e.g., friends, spouses, children) (26, 27) . Regarding spirituality, patients with HF and poor health status report worse spiritual well-being compared to patients with metastatic lung and pancreatic cancer (28) .
The assessment and treatment of physical symptoms and psychosocial-spiritual distress in HF should be the responsibility of patients' ongoing care providers (i.e., primary care, cardiology, mental health) and community supports. Yet the assessment and treatment of HF symptoms need not wait until the point of intractability; palliative care principles should be integrated throughout the HF management continuum, allowing cardiology and primary care clinicians to serve as primary palliative care providers, alleviating symptoms before they become overly burdensome. Although the role of palliative care specialists is still being defined, if patient distress persists and palliative care specialists are available, referral should be considered.
Hospitalization and Discharge
Patients with HF have a higher rate of acute care service utilization in the 30 days before death than patients with cancer (ED visits: 64% vs. 39%, hospitalizations: 60% vs. 45%, and ICU admissions: 19% vs. 7%) (29) (30) (31) (32) (33) (34) . Each hospital admission is an opportunity to discuss goals of care, as this is most likely when the treatment regimen for a patient with HF may escalate. As the risk for mortality increases with each subsequent hospitalization, hospital discharge planning is an opportunity to discuss what is most important, what QoL means to the patient/family, and under what circumstances they would and would not want life prolonging treatments (35) .
Furthermore, depending on the treatments initiated, the patient may require further assistance on discharge, such as home care, physical therapy, or cardiac rehabilitation. In addition, many families are intimately involved in patient care. Caregivers suffer physical, psychological and financial consequences associated with this care (27) . Therefore, clinicians should screen for caregiver burden and stress and help by providing support and counselling.
End-of-Life Transition
Although commonly conflated, palliative care and hospice are related but conceptually distinct services (17) . Palliative care is both a clinical specialty, and an overall approach to care that focuses on improving QoL and relieving suffering for patients and families facing serious illness, based on need and not prognosis. Hospice care is a specific delivery mechanism of palliative care reserved for individuals at the end of life. In contrast to palliative care, hospice eligibility (in the U.S.) requires an estimated life expectancy of six months or less, and an agreement to forego life-sustaining procedures. One exception is the U.S. Veterans Health Administration, which allows for hospice care concurrent with life-sustaining treatments.
Addressing a patient's physical, psychosocial, and existential distress need not wait until the very end of life; palliative care should be seamlessly integrated throughout the HF experience, with referral to hospice services if and when its philosophy aligns with patient and family goals. Despite this high morbidity and mortality, hospice utilization has remained low with about onethird of patients with HF receiving hospice at time of death (37) group, and were therefore eligible for inclusion. One relevant additional trial was hand selected as it was published after our initial search (45) . Each study was evaluated for risk of bias for subjective outcomes (e.g., patient-reported outcomes) and objective outcomes (e.g., survival, resource utilization) using the Cochrane Risk of Bias tool (46) . A complete description of the search and analytic methodology is available elsewhere (13) . Although this search is restricted to six studies of the strongest methodological design (i.e., RCTs), it should be noted that some quasi-experimental and observational studies have demonstrated potential benefits of palliative care interventions in HF patients (47) (48) (49) (50) .
Inpatient Specialty Consultation or Co-management
Two RCTs of inpatient specialty team-based consultation yielded mixed results about the impact of palliative care on healthcare utilization, yet provide some evidence for potential benefits of palliative care on patient-level outcomes (Table 1) . However, because both trials were deemed to be at high risk of bias results should be interpreted cautiously.
A 2015 trial compared the impact of inpatient consultation by a palliative care team versus usual care for patients hospitalized for acute HF (51) . The authors reported statistically significant improvements for all patient-reported outcomes measured, including QoL, symptom burden, and mood. There was no effect on patient survival. Although the intervention was associated with increased advance care planning, no effect was found regarding 30-day hospital readmission, nor on hospice referral. Strengths of this study included the use of a multi-professional team approach similar to the ideal model of palliative care delivery in inpatient settings (i.e. palliative care physicians, advance practice nurses, social workers, and chaplains).
However, given that patients in the trial were financially responsible for any subsequent palliative care visits, the majority of patients (80%) received only one visit which does not allow comment on the effects of a more longitudinal palliative approach.
Hopp and colleagues evaluated the effect of inpatient palliative care consultation within three urban U.S. hospitals (n=85). Intervention content included symptom assessment and management, elicitation of goals of care, advance care planning, and discharge planning (52) . No effect was found regarding the trial's composite primary outcome at 3-6-month follow-up of hospice utilization or the creation of a "do not resuscitate" order during or after the index hospitalization (difference, 9.3%), but with wide confidence intervals (95% CI −11.8% to 30.0%; p = 0.12). No statistically significant effect was found regarding patient survival (p=0.47).
Outpatient Specialty Palliative Care
The most compelling evidence of the benefits of palliative care in HF arguably comes from the recently published PAL-HF (Palliative Care in Heart Failure) study (low risk of bias; The trial also reported statistically significant improvements in secondary outcomes such as mood, and spiritual wellbeing. The intervention was not found to be associated with mortality or re-hospitalization.
Home-Based Specialty Palliative Care
Two RCTs of home-based palliative care interventions enrolled individuals with advanced disease (NYHA class III-IV) and provided palliative content embedded within a larger framework of disease management, including care coordination and a multidisciplinary team approach (Table 3 ) (53, 54) . Although results are generally promising, both trials were deemed to be at high risk of bias; therefore, findings should be cautiously interpreted (13) .
Brännström and colleagues conducted a trial of a home-based integrated HF disease management and palliative care intervention delivered by a multidisciplinary team(54).
Compared to usual care, patients who received the palliative care intervention reported statistically significant improvements in QoL at six weeks, despite no effect on symptom burden.
The intervention was associated with fewer hospitalizations over six months (mean 0.42 vs 1.47, p=0.009), while there was no association identified regarding total costs of care. In addition, a greater proportion of patients in the intervention group experienced improvement in NYHA functional class at six months (39% vs. 9%, p=0.015).
In a trial of transitional palliative care, Wong and colleagues randomized 84 patients recently discharged from the hospital to receive a combination of home visits and telephone check-ins from palliative care home nurses, or an attention control (i.e., social phone calls regarding unrelated topics) (53) . At twelve-week follow-up, intervention patients had significantly fewer hospital readmissions than control patients (relative risk (95% CI), 0.55 (0.35, 0.88)), and higher satisfaction with their healthcare. At 12 weeks, the intervention was also associated with reduced symptom burden, and improved QoL.
Primary Palliative Care
We identified one RCT of a primary palliative care intervention for patients with HF (unclear risk of bias due to potential concerns regarding intervention fidelity; 
Summary of evidence
Six palliative care intervention trials met inclusion criteria. Although the evidence base for palliative care in HF is nascent, there is somewhat consistent evidence that a palliative approach improves a variety of patient-centered outcomes, including symptom burden and QoL.
Nevertheless, it is clear that research regarding palliative care in HF is still developing, and due to concerns regarding risk of bias in the majority of included trials, conclusions should be interpreted cautiously. Yet, recent evidence from the high-quality PAL-HF trial provides support for the notion that longitudinal palliative care, provided concomitantly with usual HF management, is associated with improved patient-centered outcomes (45) .
EXISTING CLINICAL GUIDELINES REGARDING PALLIATIVE CARE IN HF
There 
PRIORITIES FOR FUTURE RESEARCH AND CLINICAL IMPLEMENTATION OF PALLIATIVE CARE IN HF
To date, the rationale for palliative care in HF has largely been one of analogy from the benefits reported from studies of palliative care in oncology. Yet, it is neither likely nor appropriate to assume that the framework of palliative care used in oncology is optimal for patients living with chronic, non-malignant illnesses, such as HF. Indeed, the next era of palliative care research and clinical implementation will challenge the status quo of palliative care, both in terms of content and structure, to maximize impact and uptake in chronic illness.(58) Whereas few randomized trials of palliative care interventions exist in HF, as we have illustrated, these trials are an important yet imperfect starting point for future investigation.
Three critical questions remain unanswered in the literature representing the next priorities in explicating the role of palliative care in HF.
First, how do we build capacity in addressing the unmet palliative needs of patients with HF? True innovation regarding the ability to disseminate and sustain palliative care will disrupt the prevailing reliance on the increasingly scarce resource of palliative care specialists (59) .
Indeed, all clinicians caring for patients with serious illness, like HF, should possess a fundamental palliative proficiency to alleviate suffering (e.g., basic management of physical and psychological symptoms, eliciting goals of care, responding to family concerns) (14) . Initial efforts to educate cardiology fellows in palliative care competencies, such as communication, are underway (60, 61) . Research is needed to understand how to improve education regarding primary palliative care domains that are relevant to patients with advanced HF, such as elicitation of goals of care, advance care planning, and caregiver support. As a result, not only is palliative care normalized, it is also able to be provided seamlessly and longitudinally across the HF experience -not solely in the inpatient setting in response to acute decompensation crises.
Indeed, multiple aspects of palliative care (e.g., symptom self-management, care coordination, decision support, patient activation) align with principles of disease management and HF self-care (62, 63) . For example, primary clinicians should provide proactive education and support to patients to promote self-management of burdensome symptoms, while offering specialty palliative care resources as an option if these needs become intractable. Furthermore, for patients without complex palliative concerns, it may be unnecessary to involve a palliative care specialist, which could further fragment care (14) . We present suggested roles for primary and specialty palliative care in HF in (64), no head-to-head trial has evaluated this model against in-person palliative care. It is unclear whether palliative care delivered remotely is equivalent to the arguably more resource-intensive method of in-person consultation. To ensure maximal relevance, these studies must simultaneously assess patient (e.g., QoL, symptom burden), caregiver (e.g., burden, mood), and health system outcomes (e.g., utilization, costs).
Third, which treatments are most effective for addressing symptom burden in patients with HF? Although the most common symptoms for patients with HF are well known to be depression, anxiety, sleep disturbance, fatigue, dyspnea, and pain (48, 65, 66) , additional studies are needed to expand the range of effective treatment modalities for these symptoms. For example, recent intervention studies of psychiatric comorbidity in HF have failed to yield a clear conclusion of the effectiveness of treatments (67) . This is likely due to differences in the underlying pathophysiology of these symptoms, which may differ in cardiac versus non-cardiac conditions (68, 69) . Given this gap in the literature, it remains challenging to effectively treat these very burdensome symptoms. Furthermore, due to often extreme medical complexity and frailty in this population, it can often be additionally difficult to discern a distinct symptom from progression of the overall disease process (e.g. fatigue due to depression or due to HF).
Relatedly, the severity of perceived symptoms notoriously reflects poorly the degree of underlying cardiac pathophysiology. For example, dyspnea is experienced in up to 90% of patients with HF(70), yet this is frequently in the absence of hypoxemia or hypercapnia (71) . In addition, physiological measures of disease severity, such as ejection fraction, may be inadequate proxies for health status and other subjective markers of well-being (72) . Idiosyncrasies such as these further complicate studies of potential palliative treatments due to the difficulty of establishing appropriate subject inclusion and response criteria for these symptoms.
CONCLUSION
Although the evidence base for palliative care in HF is in its infancy (73, 74) , interest in this area continues to proliferate as evidenced by the recent publication of the groundbreaking PAL-HF trial, as well as multiple clinical trials also underway examining various forms of palliative care delivery in HF. Given the growing prevalence of HF, the integration of palliative care within HF management represents an opportunity to affect the public health issue of poor QoL in patients and caregivers, while also optimizing care delivery. Furthermore, research and clinical implementation of palliative care in HF can serve as a vanguard for explicating the role of palliative care in other chronic, non-malignant illnesses.
FIGURE TITLES AND LEGENDS
Central Illustration. Integrating Palliative Care Across the Heart Failure Experience
Legend: Core domains of primary palliative care (e.g., symptom assessment and management, psychosocial support, advance care planning) may be seamlessly integrated within usual HF disease and device management. When appropriate, specialty palliative care services may be initiated to address complex or intractable palliative needs. The timing of these referrals should be based on patient need, not prognosis, and can be initiated at any point during the HF trajectory. Stars depict key events, such as acute decompensation or hospitalization, that may be particularly salient opportunities for evaluation of appropriateness for specialty palliative care referral or hospice referral, if aligned with a patient's goals. Given that symptoms, functional status, and QoL are not perfectly correlated, it is important that palliative needs such as symptoms and QoL be routinely and systematically monitored throughout the patient's HF care trajectory. Abbreviations: HF, heart failure. PPC, primary palliative care. SPC, specialty palliative care.
LVAD, left ventricular assist device. TJC, The Joint Commission. CPR, cardiopulmonary resuscitation.
